nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.167	0.346	CbGbCtD
Hydroxychloroquine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.167	0.346	CbGbCtD
Hydroxychloroquine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.148	0.308	CbGbCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—LY96—chronic obstructive pulmonary disease	0.0079	0.0478	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—SFTPD—chronic obstructive pulmonary disease	0.00674	0.0408	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—LY96—chronic obstructive pulmonary disease	0.00624	0.0378	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—LY96—chronic obstructive pulmonary disease	0.00617	0.0373	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—LY96—chronic obstructive pulmonary disease	0.0061	0.0369	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—SFTPD—chronic obstructive pulmonary disease	0.00533	0.0323	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—LY96—chronic obstructive pulmonary disease	0.00487	0.0295	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—LY96—chronic obstructive pulmonary disease	0.00482	0.0292	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—KL—chronic obstructive pulmonary disease	0.00369	0.0223	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TLR2—chronic obstructive pulmonary disease	0.00359	0.0217	CbGpPWpGaD
Hydroxychloroquine—Primaquine—CYP1A1—chronic obstructive pulmonary disease	0.00353	0.236	CrCbGaD
Hydroxychloroquine—Primaquine—CYP1A2—chronic obstructive pulmonary disease	0.00341	0.228	CrCbGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KL—chronic obstructive pulmonary disease	0.00308	0.0187	CbGpPWpGaD
Hydroxychloroquine—Amodiaquine—CYP1A1—chronic obstructive pulmonary disease	0.003	0.201	CrCbGaD
Hydroxychloroquine—TLR9—IRS-related events—KL—chronic obstructive pulmonary disease	0.003	0.0182	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KL—chronic obstructive pulmonary disease	0.00297	0.018	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KL—chronic obstructive pulmonary disease	0.00289	0.0175	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KL—chronic obstructive pulmonary disease	0.00289	0.0175	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—TNF—chronic obstructive pulmonary disease	0.00286	0.191	CrCbGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR2—chronic obstructive pulmonary disease	0.00283	0.0172	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TLR2—chronic obstructive pulmonary disease	0.0028	0.0169	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TLR2—chronic obstructive pulmonary disease	0.00277	0.0168	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KL—chronic obstructive pulmonary disease	0.0024	0.0146	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TLR4—chronic obstructive pulmonary disease	0.00222	0.0134	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR2—chronic obstructive pulmonary disease	0.00221	0.0134	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TLR2—chronic obstructive pulmonary disease	0.00219	0.0132	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—CYP1A1—chronic obstructive pulmonary disease	0.00217	0.145	CrCbGaD
Hydroxychloroquine—TLR7—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.00197	0.012	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00188	0.0114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TLR4—chronic obstructive pulmonary disease	0.00175	0.0106	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—chronic obstructive pulmonary disease	0.00173	0.0105	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.00171	0.0104	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00157	0.00951	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.00156	0.00945	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00151	0.00914	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	0.0015	0.0091	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00147	0.00435	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00434	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00432	CcSEcCtD
Hydroxychloroquine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00432	CcSEcCtD
Hydroxychloroquine—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00427	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.00144	0.00873	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00416	CcSEcCtD
Hydroxychloroquine—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00415	CcSEcCtD
Hydroxychloroquine—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00414	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.0041	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TLR4—chronic obstructive pulmonary disease	0.00137	0.00828	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00136	0.00826	CbGpPWpGaD
Hydroxychloroquine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00402	CcSEcCtD
Hydroxychloroquine—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.00135	0.004	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.00135	0.00818	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00135	0.00398	CcSEcCtD
Hydroxychloroquine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00134	0.00398	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00396	CcSEcCtD
Hydroxychloroquine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00132	0.0039	CcSEcCtD
Hydroxychloroquine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00388	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00387	CcSEcCtD
Hydroxychloroquine—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00386	CcSEcCtD
Hydroxychloroquine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00376	CcSEcCtD
Hydroxychloroquine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00376	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00369	CcSEcCtD
Hydroxychloroquine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00364	CcSEcCtD
Hydroxychloroquine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00122	0.00359	CcSEcCtD
Hydroxychloroquine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00355	CcSEcCtD
Hydroxychloroquine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00353	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—CXCL8—chronic obstructive pulmonary disease	0.00119	0.00719	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.00118	0.00716	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	0.00117	0.0071	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00117	0.00706	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00345	CcSEcCtD
Hydroxychloroquine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00345	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00343	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—LY96—chronic obstructive pulmonary disease	0.00115	0.00696	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.0034	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00339	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00338	CcSEcCtD
Hydroxychloroquine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00114	0.00691	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL1B—chronic obstructive pulmonary disease	0.00114	0.0069	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	0.00113	0.00681	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00331	CcSEcCtD
Hydroxychloroquine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00331	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00328	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00326	CcSEcCtD
Hydroxychloroquine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0011	0.00664	CbGpPWpGaD
Hydroxychloroquine—Contusion—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00321	CcSEcCtD
Hydroxychloroquine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00108	0.00319	CcSEcCtD
Hydroxychloroquine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00108	0.00318	CcSEcCtD
Hydroxychloroquine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00316	CcSEcCtD
Hydroxychloroquine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00107	0.00316	CcSEcCtD
Hydroxychloroquine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00315	CcSEcCtD
Hydroxychloroquine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00315	CcSEcCtD
Hydroxychloroquine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00314	CcSEcCtD
Hydroxychloroquine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00314	CcSEcCtD
Hydroxychloroquine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00314	CcSEcCtD
Hydroxychloroquine—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00312	CcSEcCtD
Hydroxychloroquine—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00312	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.00105	0.00633	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00104	0.00309	CcSEcCtD
Hydroxychloroquine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00307	CcSEcCtD
Hydroxychloroquine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00306	CcSEcCtD
Hydroxychloroquine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00306	CcSEcCtD
Hydroxychloroquine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00306	CcSEcCtD
Hydroxychloroquine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00303	CcSEcCtD
Hydroxychloroquine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00303	CcSEcCtD
Hydroxychloroquine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00298	CcSEcCtD
Hydroxychloroquine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00296	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.001	0.00296	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000997	0.00604	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000995	0.00294	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000991	0.00293	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000982	0.0029	CcSEcCtD
Hydroxychloroquine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000976	0.00289	CcSEcCtD
Hydroxychloroquine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000968	0.00286	CcSEcCtD
Hydroxychloroquine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000968	0.00286	CcSEcCtD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	0.000968	0.00586	CbGpPWpGaD
Hydroxychloroquine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000966	0.00286	CcSEcCtD
Hydroxychloroquine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000962	0.00285	CcSEcCtD
Hydroxychloroquine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000962	0.00285	CcSEcCtD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	0.00095	0.00575	CbGpPWpGaD
Hydroxychloroquine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000948	0.0028	CcSEcCtD
Hydroxychloroquine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000943	0.00279	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000935	0.00566	CbGpPWpGaD
Hydroxychloroquine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000932	0.00276	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	0.000927	0.00561	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000924	0.00273	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00092	0.00272	CcSEcCtD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	0.000917	0.00555	CbGpPWpGaD
Hydroxychloroquine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000914	0.0027	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—LY96—chronic obstructive pulmonary disease	0.000909	0.0055	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000909	0.00269	CcSEcCtD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000904	0.00547	CbGpPWpGaD
Hydroxychloroquine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000897	0.00265	CcSEcCtD
Hydroxychloroquine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000897	0.00265	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000897	0.00543	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000894	0.00264	CcSEcCtD
Hydroxychloroquine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000894	0.00264	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000893	0.00264	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000893	0.00264	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000891	0.00263	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000891	0.00263	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	0.00089	0.00539	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000874	0.00259	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000872	0.00258	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000871	0.00258	CcSEcCtD
Hydroxychloroquine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00086	0.00254	CcSEcCtD
Hydroxychloroquine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00086	0.00254	CcSEcCtD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000847	0.00513	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000846	0.0025	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000844	0.00511	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000843	0.00249	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000843	0.00249	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000843	0.0051	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000842	0.00249	CcSEcCtD
Hydroxychloroquine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000842	0.00249	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000835	0.00247	CcSEcCtD
Hydroxychloroquine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000835	0.00247	CcSEcCtD
Hydroxychloroquine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000835	0.00247	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000832	0.00246	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—chronic obstructive pulmonary disease	0.000827	0.00501	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000826	0.00244	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000824	0.00244	CcSEcCtD
Hydroxychloroquine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000818	0.00242	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	0.000817	0.00494	CbGpPWpGaD
Hydroxychloroquine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000812	0.0024	CcSEcCtD
Hydroxychloroquine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000799	0.00236	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000796	0.00235	CcSEcCtD
Hydroxychloroquine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.00233	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000785	0.00232	CcSEcCtD
Hydroxychloroquine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000774	0.00229	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000773	0.00229	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—chronic obstructive pulmonary disease	0.000772	0.00467	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	0.000765	0.00463	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000764	0.00226	CcSEcCtD
Hydroxychloroquine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000764	0.00226	CcSEcCtD
Hydroxychloroquine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000754	0.00223	CcSEcCtD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	0.000751	0.00455	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—chronic obstructive pulmonary disease	0.000751	0.00455	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000749	0.00221	CcSEcCtD
Hydroxychloroquine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000747	0.00221	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—chronic obstructive pulmonary disease	0.000744	0.00451	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00219	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00219	CcSEcCtD
Hydroxychloroquine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000741	0.00219	CcSEcCtD
Hydroxychloroquine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000741	0.00219	CcSEcCtD
Hydroxychloroquine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000735	0.00217	CcSEcCtD
Hydroxychloroquine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000735	0.00217	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000727	0.00215	CcSEcCtD
Hydroxychloroquine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000726	0.00215	CcSEcCtD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—chronic obstructive pulmonary disease	0.000725	0.00439	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—chronic obstructive pulmonary disease	0.000725	0.00439	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	0.000725	0.00439	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000722	0.00213	CcSEcCtD
Hydroxychloroquine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00072	0.00213	CcSEcCtD
Hydroxychloroquine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000718	0.00212	CcSEcCtD
Hydroxychloroquine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000712	0.00211	CcSEcCtD
Hydroxychloroquine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000711	0.0021	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000709	0.00429	CbGpPWpGaD
Hydroxychloroquine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000708	0.00209	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000706	0.00209	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000705	0.00209	CcSEcCtD
Hydroxychloroquine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000704	0.00208	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000703	0.00208	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000703	0.00208	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000701	0.00207	CcSEcCtD
Hydroxychloroquine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.0007	0.00207	CcSEcCtD
Hydroxychloroquine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000694	0.00205	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000688	0.00204	CcSEcCtD
Hydroxychloroquine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000683	0.00202	CcSEcCtD
Hydroxychloroquine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000683	0.00202	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00068	0.00201	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00068	0.00201	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00068	0.00201	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00068	0.00201	CcSEcCtD
Hydroxychloroquine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000677	0.002	CcSEcCtD
Hydroxychloroquine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000677	0.002	CcSEcCtD
Hydroxychloroquine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000672	0.00199	CcSEcCtD
Hydroxychloroquine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000672	0.00199	CcSEcCtD
Hydroxychloroquine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000671	0.00198	CcSEcCtD
Hydroxychloroquine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000671	0.00198	CcSEcCtD
Hydroxychloroquine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000669	0.00198	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	0.000667	0.00404	CbGpPWpGaD
Hydroxychloroquine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000667	0.00197	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000667	0.00404	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000666	0.00403	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000666	0.00197	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000666	0.00197	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000664	0.00196	CcSEcCtD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	0.000659	0.00399	CbGpPWpGaD
Hydroxychloroquine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000659	0.00195	CcSEcCtD
Hydroxychloroquine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000657	0.00194	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000655	0.00194	CcSEcCtD
Hydroxychloroquine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000652	0.00193	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000652	0.00395	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000652	0.00394	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	0.000646	0.00391	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000645	0.00191	CcSEcCtD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000643	0.0039	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.0019	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.0019	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000633	0.00187	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000633	0.00187	CcSEcCtD
Hydroxychloroquine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000633	0.00187	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000632	0.00383	CbGpPWpGaD
Hydroxychloroquine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000631	0.00187	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00062	0.00183	CcSEcCtD
Hydroxychloroquine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000617	0.00182	CcSEcCtD
Hydroxychloroquine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.00182	CcSEcCtD
Hydroxychloroquine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.0018	CcSEcCtD
Hydroxychloroquine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000608	0.0018	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000607	0.0018	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000604	0.00366	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00179	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—chronic obstructive pulmonary disease	0.000602	0.00365	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00177	CcSEcCtD
Hydroxychloroquine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000596	0.00176	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.00174	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000588	0.00174	CcSEcCtD
Hydroxychloroquine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000582	0.00172	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000578	0.0035	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000576	0.0017	CcSEcCtD
Hydroxychloroquine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000574	0.0017	CcSEcCtD
Hydroxychloroquine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00168	CcSEcCtD
Hydroxychloroquine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00168	CcSEcCtD
Hydroxychloroquine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000557	0.00165	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00164	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000554	0.00335	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000547	0.00162	CcSEcCtD
Hydroxychloroquine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000547	0.00162	CcSEcCtD
Hydroxychloroquine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000542	0.0016	CcSEcCtD
Hydroxychloroquine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000542	0.0016	CcSEcCtD
Hydroxychloroquine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000541	0.0016	CcSEcCtD
Hydroxychloroquine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000541	0.0016	CcSEcCtD
Hydroxychloroquine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000539	0.00159	CcSEcCtD
Hydroxychloroquine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000539	0.00159	CcSEcCtD
Hydroxychloroquine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000538	0.00159	CcSEcCtD
Hydroxychloroquine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000538	0.00159	CcSEcCtD
Hydroxychloroquine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.00159	CcSEcCtD
Hydroxychloroquine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000535	0.00158	CcSEcCtD
Hydroxychloroquine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000531	0.00157	CcSEcCtD
Hydroxychloroquine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00053	0.00157	CcSEcCtD
Hydroxychloroquine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000529	0.00156	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000529	0.0032	CbGpPWpGaD
Hydroxychloroquine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000527	0.00156	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TLR2—chronic obstructive pulmonary disease	0.000522	0.00316	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.00154	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	0.000521	0.00315	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000516	0.00153	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000515	0.00312	CbGpPWpGaD
Hydroxychloroquine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000512	0.00152	CcSEcCtD
Hydroxychloroquine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000512	0.00151	CcSEcCtD
Hydroxychloroquine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000511	0.00151	CcSEcCtD
Hydroxychloroquine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000511	0.00151	CcSEcCtD
Hydroxychloroquine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000511	0.00151	CcSEcCtD
Hydroxychloroquine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000508	0.0015	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000501	0.00148	CcSEcCtD
Hydroxychloroquine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0005	0.00148	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000499	0.00302	CbGpPWpGaD
Hydroxychloroquine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.00146	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—KL—chronic obstructive pulmonary disease	0.000491	0.00297	CbGpPWpGaD
Hydroxychloroquine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000482	0.00143	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000479	0.00142	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000476	0.00141	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000474	0.00287	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000467	0.00283	CbGpPWpGaD
Hydroxychloroquine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000466	0.00138	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000458	0.00277	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000457	0.00276	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000445	0.00132	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000438	0.00265	CbGpPWpGaD
Hydroxychloroquine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000421	0.00124	CcSEcCtD
Hydroxychloroquine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00123	CcSEcCtD
Hydroxychloroquine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000414	0.00123	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—TLR2—chronic obstructive pulmonary disease	0.000413	0.0025	CbGpPWpGaD
Hydroxychloroquine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000398	0.00118	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CD8A—chronic obstructive pulmonary disease	0.000396	0.0024	CbGpPWpGaD
Hydroxychloroquine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00116	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—KL—chronic obstructive pulmonary disease	0.000388	0.00235	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000384	0.00232	CbGpPWpGaD
Hydroxychloroquine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000383	0.00113	CcSEcCtD
Hydroxychloroquine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000381	0.00113	CcSEcCtD
Hydroxychloroquine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000379	0.00112	CcSEcCtD
Hydroxychloroquine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000372	0.0011	CcSEcCtD
Hydroxychloroquine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00109	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000369	0.00223	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000368	0.00223	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000364	0.00108	CcSEcCtD
Hydroxychloroquine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00106	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00035	0.00104	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000343	0.00101	CcSEcCtD
Hydroxychloroquine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000338	0.001	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000338	0.00205	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CRP—chronic obstructive pulmonary disease	0.000337	0.00204	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000334	0.00202	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000981	CcSEcCtD
Hydroxychloroquine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000972	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—TLR4—chronic obstructive pulmonary disease	0.000323	0.00195	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000322	0.000954	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CD8A—chronic obstructive pulmonary disease	0.000313	0.00189	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000308	0.000911	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00087	CcSEcCtD
Hydroxychloroquine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.000868	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000293	0.000867	CcSEcCtD
Hydroxychloroquine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000863	CcSEcCtD
Hydroxychloroquine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.000863	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000291	0.00176	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000281	0.0017	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000277	0.00168	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000818	CcSEcCtD
Hydroxychloroquine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000277	0.000818	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000275	0.00166	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.00027	0.00163	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000795	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000791	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000791	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CRP—chronic obstructive pulmonary disease	0.000266	0.00161	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TLR4—chronic obstructive pulmonary disease	0.000255	0.00154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000251	0.00152	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000737	CcSEcCtD
Hydroxychloroquine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000718	CcSEcCtD
Hydroxychloroquine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000708	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000234	0.00142	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000232	0.0014	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000685	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000231	0.0014	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000662	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000217	0.00131	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000215	0.0013	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000636	CcSEcCtD
Hydroxychloroquine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000631	CcSEcCtD
Hydroxychloroquine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00063	CcSEcCtD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000212	0.00128	CbGpPWpGaD
Hydroxychloroquine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000627	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—chronic obstructive pulmonary disease	0.000211	0.00128	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—chronic obstructive pulmonary disease	0.00021	0.00127	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000207	0.00125	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000204	0.00123	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.00122	CbGpPWpGaD
Hydroxychloroquine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000594	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000188	0.00114	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000181	0.0011	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000168	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—chronic obstructive pulmonary disease	0.000167	0.00101	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—chronic obstructive pulmonary disease	0.000166	0.001	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000164	0.000994	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—EGFR—chronic obstructive pulmonary disease	0.00016	0.000968	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000132	0.0008	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—EGFR—chronic obstructive pulmonary disease	0.000126	0.000765	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000126	0.000763	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—chronic obstructive pulmonary disease	0.000123	0.000744	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000112	0.000677	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000109	0.000658	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	0.000106	0.00064	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000101	0.000612	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.83e-05	0.000595	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—chronic obstructive pulmonary disease	9.72e-05	0.000588	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.08e-05	0.00055	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.34e-05	0.000505	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.17e-05	0.000495	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.86e-05	0.000416	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.28e-05	0.00038	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.78e-05	0.00035	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.71e-05	0.000346	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.21e-05	0.000315	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.8e-05	0.000291	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4e-05	0.000242	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.95e-05	0.000239	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.68e-05	0.000223	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.49e-05	0.000211	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.37e-05	0.000144	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.27e-05	0.000137	CbGpPWpGaD
